In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes. Issue 18 (6th February 2019)
- Record Type:
- Journal Article
- Title:
- In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes. Issue 18 (6th February 2019)
- Main Title:
- In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
- Authors:
- Velozo-Sá, Vivianne S.
Pereira, Luciano R.
Lima, Aliny P.
Mello-Andrade, Francyelli
Rezende, Manuela R. M.
Goveia, Rebeca M.
Pires, Wanessa C.
Silva, Monize M.
Oliveira, Katia M.
Ferreira, Antonio G.
Ellena, Javier
Deflon, Victor M.
Grisolia, Cesar Koppe
Batista, Alzir A.
Silveira-Lacerda, Elisângela P. - Abstract:
- Abstract : Ru(ii )/2-mercaptopyrimidine complexes active against cancer cells did not present toxic effects during embryonic and larval development of zebrafish. Abstract : In this paper, four new ruthenium complexes, [Ru(N–S)(dppm)2 ]PF6 (1 ), [Ru(N–S)(dppe)2 ]PF6 (2 ), [Ru(N–S)2 (dppp)] (3 ) and [Ru(N–S)2 (PPh3 )2 ] (4 ) [dppm = 1, 1-bis(diphenylphosphino)methane, dppe = 1, 2-bis(diphenylphosphino)ethane, dppp = 1, 3-bis(diphenylphosphino)propane, PPh3 = triphenylphosphine and N–S = 2-mercaptopyrimidine anion] were synthesized and characterized using spectroscopy techniques, molar conductance, elemental analysis, electrochemical techniques and X-ray diffraction. The DNA binding studies were investigated using voltammetry and spectroscopy techniques. The results show that all complexes exhibit a weak interaction with DNA. HSA interaction with the complexes was studied using fluorescence emission spectroscopy, where the results indicate a spontaneous interaction between the species by a static quenching mechanism. The cytotoxicity of the complexes was evaluated against A549, MDA-MB-231 and HaCat cells by MTT assay. Complexes (1 ) and (2 ), which are very active against triple negative MDA-MB-231, were subjected to further biological tests with this cell line. The cytotoxic activity triggered by the complexes was confirmed by clonogenic assay. Cell cycle analyses demonstrated marked anti-proliferative effects, especially at the G0/G1 and S phases. The morphological detectionAbstract : Ru(ii )/2-mercaptopyrimidine complexes active against cancer cells did not present toxic effects during embryonic and larval development of zebrafish. Abstract : In this paper, four new ruthenium complexes, [Ru(N–S)(dppm)2 ]PF6 (1 ), [Ru(N–S)(dppe)2 ]PF6 (2 ), [Ru(N–S)2 (dppp)] (3 ) and [Ru(N–S)2 (PPh3 )2 ] (4 ) [dppm = 1, 1-bis(diphenylphosphino)methane, dppe = 1, 2-bis(diphenylphosphino)ethane, dppp = 1, 3-bis(diphenylphosphino)propane, PPh3 = triphenylphosphine and N–S = 2-mercaptopyrimidine anion] were synthesized and characterized using spectroscopy techniques, molar conductance, elemental analysis, electrochemical techniques and X-ray diffraction. The DNA binding studies were investigated using voltammetry and spectroscopy techniques. The results show that all complexes exhibit a weak interaction with DNA. HSA interaction with the complexes was studied using fluorescence emission spectroscopy, where the results indicate a spontaneous interaction between the species by a static quenching mechanism. The cytotoxicity of the complexes was evaluated against A549, MDA-MB-231 and HaCat cells by MTT assay. Complexes (1 ) and (2 ), which are very active against triple negative MDA-MB-231, were subjected to further biological tests with this cell line. The cytotoxic activity triggered by the complexes was confirmed by clonogenic assay. Cell cycle analyses demonstrated marked anti-proliferative effects, especially at the G0/G1 and S phases. The morphological detection of apoptosis and necrosis – HO/PI and Annexin V-FITC/PI assay, elucidated that the type of cell death triggered by these complexes was probably by apoptosis. The in vivo toxicological assessment performed on zebrafish embryos revealed that complexes (1 ) and (2 ) did not present embryotoxic or toxic effects during embryonic and larval development showing that they are promising new prototypes of safer and more effective drugs for triple negative breast cancer treatment. … (more)
- Is Part Of:
- Dalton transactions. Volume 48:Issue 18(2019)
- Journal:
- Dalton transactions
- Issue:
- Volume 48:Issue 18(2019)
- Issue Display:
- Volume 48, Issue 18 (2019)
- Year:
- 2019
- Volume:
- 48
- Issue:
- 18
- Issue Sort Value:
- 2019-0048-0018-0000
- Page Start:
- 6026
- Page End:
- 6039
- Publication Date:
- 2019-02-06
- Subjects:
- Chemistry, Inorganic -- Periodicals
Chemistry, Physical and theoretical -- Periodicals
Chemistry, Inorganic -- Periodicals
546.05 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/dt#!issueid=dt043040&type=current&issnprint=1477-9226 ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c8dt03738h ↗
- Languages:
- English
- ISSNs:
- 1477-9226
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3517.830000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 10393.xml